Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neuropharm Group PLC

Latest From Neuropharm Group PLC

Stockwatch: They shoot biotech horses don't they?

This year, as well as last, the death of two horses at the recent UK Grand National race has led to a considerable amount of consternation amongst the horseracing, and even the general community. Interestingly, there are striking similarities between what has led to the death of so many UK biotechnology companies, and the changes that have led to the deaths at the Grand National.

Stockwatch: Can bankers break biotech?

The recent outpouring of soul searching, introspection and discussion prompted by the parting editorial from Greg Smith, a now ex-Goldman Sachs investment banker, has had little linkage to the biotechnology sector. [Smith proposed in his resignation letter that career progression at Goldman Sachs is now contingent not on making money for its investor clients but on making money for Goldman Sachs.]

Cancer Switzerland

Neuropharm proposes liquidation

Neuropharm has recommended to its shareholders that its operations be wound up by way of voluntary liquidation.

Dermatology Wound Healing & Tissue Repair

Neuropharm considers voluntary liquidation

Neuropharm is considering voluntary liquidation and a return of cash to shareholders as attempts to secure a sale or merger of the company have yet to come to fruition.

Neurology Companies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Neuropharm Group PLC
  • Senior Management
  • Robert Mansfield, CEO
    Graham Yeatman, CFO
    Mike Snape, PhD, CSO
    Maria Dzaleta, VP, Bus. Dev.
  • Contact Info
  • Neuropharm Group PLC
    Phone: (44)
    Fetcham Park House
    Lower Rd.
    Leatherhead, KT22 9HD